The use of a risk group stratification in the management of invasive fungal infection: A prospective validation

British Journal of Haematology

Volumn 124, Issue 3, 2004, Pages 403-404

  McLintock, L A ^a   Jordanides, N E ^a   Allan, E K ^a   Copland, M ^a   Stewart, K ^a   Parker, A ^b   Devaney, M ^c   Holyoake, T L ^a   Jones, B L ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c NHS LOTHIAN   (United Kingdom)

Author keywords

Antifungal therapy; Invasive fungal infection; Polymerase chain reaction; Risk stratification

Indexed keywords

ANTIFUNGAL AGENT;

ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; CHEMOTHERAPY; EARLY DIAGNOSIS; FUNGUS; HUMAN; IMMUNE DEFICIENCY; INFORMED CONSENT; LETTER; MYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; STRATIFICATION; VALIDATION PROCESS;

HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; OPPORTUNISTIC INFECTIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 0842330398     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04794.x     Document Type: Letter

References (4)

1. Ascioglu, S., Rex, J.H., de Pauw, B., Bennett, J.E., Billie, J., Crokaert, F., Denning, D.W., Donnelly, J.P., Edwards, J.E., Erjavec, Z., Fiere, D., Lortholary, O., Maertens, J., Meis, J.F., Patterson, T.F., Ritter, J., Selleslag, D., Shah, P.M., Stevens, D.A. & Walsh, T.J. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical Infectious Disease, 34, 7-14.
2. Lin, S., Schranz, J. & Teutsch, S.M. (2001) Aspergillosis case-fatality rate: systemic review of literature. Clinical Infectious Disease, 32, 358-366.
3. Marr, K.A., Carter, R.A., Boeckh, M., Martin, P. & Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358-4366.
4. Prentice, H.G., Kibbler, C.C. & Prentice, A.G. (2000) Towards a targeted, risk-based, antifungal strategy in neutropenic patients. British Journal of Haematology, 110, 273-284.